Work

POSTER: ALL-562 Outcomes in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Receiving Inotuzumab Ozogamicin Stratified by Cumulative Dose

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)00419-7

Authors: Elias Jabbour, Anjali Advani, Nicola Gokbuget, Josep Ribera, Wendy Stock, Ryan Cassaday, Daniel J. DeAngelo, Stephanie Dorman, Sherry Williams PharmD,, Fan Zhang, Eric Vandendries, Hagop Kantarjian

Institutions: The University of Texas MD Anderson Cancer Center, Cleveland Clinic, University Hospital Frankfurt, Institut Català d'Oncologia, University of Chicago, University of Washington, Fred Hutch Cancer Center, Dana-Farber Cancer Institute, Pfizer (United States)

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413776689

FWCI:

Cites:

Cited by:

Related to: 10